Neurocrine Biosciences | Валовая Прибыль





Валовая прибыль Изменить Дата
AbbVie USD 10.47B 605M 2025-09
Acadia Pharmaceuticals USD 256.99M 13.15M 2025-09
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
ALKERMES USD 265.83M 8.06M 2025-09
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Amgen USD 6.48B 307M 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Cytokinetics USD 1.94M 64.83M 2025-09
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Exelixis USD 572.18M 7M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Incyte USD 1.39B 118.68M 2025-12
Ionis Pharmaceuticals USD 155M 293M 2025-09
Nektar Therapeutics USD 13.75M 650K 2024-06
Neurocrine Biosciences USD 787.9M 7M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Prothena USD 2.42M 38.52M 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Repligen USD 100.52M 9.37M 2025-09
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Xoma 992K 846K 2024-06


Neurocrine Biosciences Валовая Прибыль - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Feb 2026.